Revolutionizing Longevity: Seasickness Drugs' Surprising Anti-Aging Effects
Learn Today to Lead Tomorrow

Revolutionizing Longevity: Seasickness Drugs' Surprising Anti-Aging Effects

Ari Horesh

Unveiling the Unexpected: Anti-Seasickness Drugs as a Key to Longevity


In a recent dialogue between Peter Attia and Rich Miller, an astonishing revelation was made about the potential anti-aging effects of common anti-seasickness drugs. This article delves into their discussion, uncovering the mechanisms and implications of this groundbreaking discovery.

The Seasickness Connection

Peter Attia's Nautical Adventures

"I've only been seasick once in my life, which, considering the amount of time I've spent on boats, I consider pretty fortunate."

Peter Attia recounts his extensive experience with seasickness during his time on boats. Despite his resilience, he observed that many around him frequently succumbed to seasickness, often resorting to over-the-counter drugs like Meine (Bonine) for relief.

The Discovery of Meine and Azane

Uncovering Anti-Aging Properties

Rich Miller introduces two drugs, Meine and Azane, initially used for seasickness, which have shown a significant increase, about 10%, in the lifespan of male mice in recent studies. This unexpected discovery emerged from research seeking FDA-approved drugs that inhibit TOR, a protein linked to aging.

The Mechanisms Behind the Miracle

How Do These Drugs Work?

  • Tour Inhibition: Initially, it was hypothesized that the anti-aging effects were due to Tour inhibition.
  • CNS Effects: However, both drugs, particularly Meine, are known for their Central Nervous System (CNS) effects, which might play a crucial role.

The Role of Serotonin and Histamine:

"Maybe the good stuff that it's doing to the male mice is unrelated to tour; maybe it has to do with changes in serotonin or histamine production..."

This quote from the discussion highlights the need for further exploration into how these drugs affect longevity.

Acanthine: A Colorful Surprise

From Salmon Farms to Longevity Labs

Acanthine, known for its use in salmon farming, emerged as another surprise. Rich Miller notes its varied alleged health benefits and its significant effect on male mice's lifespan. This opens a new avenue for exploring naturally derived compounds in anti-aging research.

Fittin: The Senolytic Hypothesis

Testing the Senescence Cell Theory

Fittin, a drug suggested for its senolytic properties – the ability to remove aging cells – was put to the test. Despite high hopes, it showed no effect on lifespan nor did it remove senescent cells, challenging the popular senescence cell theory in aging.

Implications for Human Longevity

From Mice to Men: A Leap of Faith?

While these findings are promising, their applicability to human longevity remains a question. The legal and political implications, particularly the FDA's stance on anti-aging drug testing, add layers of complexity to this discovery.

Conclusion: A New Frontier in Longevity Research

This discussion between Peter Attia and Rich Miller marks a pivotal moment in anti-aging research. It challenges traditional views and opens up exciting possibilities for future exploration. As we stand on the brink of these potential breakthroughs, one thing is certain: the journey to understanding and achieving human longevity is more intriguing than ever.

What's Next?

  • Further Research: Investigating the exact mechanisms of Meine and Azane.
  • Human Trials: Exploring the effects of these drugs on human aging.
  • Broader Impacts: Understanding the wider implications of over-the-counter drugs in longevity research.

The findings discussed by Peter Attia and Rich Miller represent a significant step forward in our quest to understand and potentially control the aging process. As we continue to explore the mysteries of longevity, the role of seemingly mundane substances like anti-seasickness drugs might prove to be more significant than we ever imagined.

Share twitter/ facebook/ copy link
Your link has expired
Success! Check your email for magic link to sign-in.